Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation.

Coleman, Craig I; Briere, Jean-Baptiste; Fauchier, Laurent; Levy, Pierre; Bowrin, Kevin; Toumi, Mondher; Millier, Aurélie; Taieb, Vanessa; Wu, Olivia

Coleman, Craig I; Briere, Jean-Baptiste; Fauchier, Laurent; Levy, Pierre; Bowrin, Kevin; Toumi, Mondher; Millier, Aurélie; Taieb, Vanessa; Wu, Olivia.

Afiliación

Coleman CI; School of Pharmacy, University of Connecticut, Storrs, CT, USA.
Briere JB; Health Economist, Bayer AG, Berlin, Germany.
Fauchier L; Cardiologie, Centre Hospitalier Universitaire Trousseau et Université François Rabelais, Tours, France.
Levy P; LEDa-LEGOS, Université Paris-Dauphine, PSL Research University, Paris, France.
Bowrin K; HEOR CV, Bayer Plc, Reading, UK.
Toumi M; Faculty of Medicine, University of Aix-Marseille, Marseille, France.
Millier A; HEOR Department, HTA Team, Creativ-Ceutical, Paris, France.
Taieb V; HEOR Department, Evidence Synthesis Team, Creativ-Ceutical, London, UK.
Wu O; HEHTA, University of Glasgow, Glasgow, UK.

J Mark Access Health Policy ; 7(1): 1574541, 2019.

Article en En | MEDLINE | ID: mdl-30774786

Palabras clave

Anticoagulation; meta-analysis; non-valvular atrial fibrillation; non-vitamin K antagonist oral anticoagulants; real-world evidence; stroke prevention

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Systematic_reviews Idioma: En Revista: J Mark Access Health Policy Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google